An untargeted proteomics analysis was undertaken to investigate responses to a cancer drug (survivin inhibitor) and look for possible prognostic biomarkers. A non-responcive cell line(T1454) and a sensitive cell line (T1459) (according to YM155 EC50 values) were selected (controls and treated cells). The same samples were anaysed using NMR (metabolomics).